There have been, recently, several reports (WHO/ FAO, 1979) emphasizing the need for development of new drugs for use against human and animal infections by members of the genus Trypanosoma. These include Trypanosoma congolen.sc, T. vivax and T. brucei brucei, which are the main causative organisms of the African animal trypanosomiasises, parasitic infections of considerable veterinary, epidemiological and economic importance (WHO/FAO, 1979) . All the drugs in current field use against these haemoflagellate parasitic protozoa were introduced more than 25 years ago and have been the subject of reports of problems in their use, such as the widespread development of resistance (Williamson, 1970) .
Recently there have been reports of trypanocidal activity of two novel compounds. a-Difluoromethyl ornithine (DFMO) has been shown to be an inhibitor of ornithine decarboxylase (Sjoerdsma, 1981) , and to cure fatal infections of T. h. hrucei (Bacchi et al., 1980 and T. congolensi (Karbe et al., 1982) Sjoerdsma & Schechter, 1984) . A structurally unrelated compound, bromoacetyl-L-carnitine (BAC), which interferes with ATP production and carnitine acetyltransferase activity in T. h. hrucei (Gilbert & Klein, 1982;  Klein c>t d.. 1982) , has been shown (Gilbert et al., 1983) to reduce motility and abolish infectivity of these organisms in vitro and to have a trypanocidal action in T. h. hrucei infected mice.
This paper describes investigations of the trypanocidal efficacy of DFMO and BAC separately and in combination against T. h. hrucei infections in rats. Rats (CFY strain) were infected with approx. 10' Trypanosoma h. hrucei (strain 427) ir mouse blood, and treated 24 h later when the parasitaemia had become patent. DFMO and BAC were used in combination and at doses as shown in Table I ; this indicates the efficacy of each combination in terms of the subsequent life duration of each rat.
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bromoacet yl-L-carnitine.
I t can be seen that although both BAC and DFMO have a trypanocidal action in vivo, neither are completely curative alone at the doses shown in Table I , and there appears to be a synergistic action of these two compounds in combination. For example, at 3% DFMO in the absence of BAC, 2/5 experimental animals survived to 30 days, whereas in the presence of BAC at either 100mg/kg or 3 x lOOmg/kg 5/5 survived. In the presence of BAC alone Oj5 survived to 30 days even at the highest doses administered. DFMO when administer:d alone at the very high dose of 6% appears to be curative, at least over the investigative period of 30 days. In Table 2 the survival times for individual animals as compared with the controls can be seen to increase significantly as the dose of either BAC and DFMO was increased. The marked synergistic effect at the highest doses when both are administered together is apparent when long-term survival is considered. The animals in the groups marked with an asterisk (Table 1) survived at least 3 months without a relapse of infection. Moreover, these animals were negative to mouse xenodiagnosis on two separate occasions, and did not show a relapse within 11 days after immuno suppression by exposure to a total body dose of 500R '"C y-radiation. These experiments indicate that the combination of BAC and DFMO was indeed curative for this strain of trypanosome in rats.
We suggest one possible mechanism for this synergistic interaction which might involve the simultaneous inhibition of the ornithine decarboxylase pathway for polyamine synthesis by DFMO, and also inhibition of the adenine pathway for S-adenosyl methionine production from ATP by BAC (Williams-Ashman et al., 1982; Saverese et al., 1983; Tisdale, 1983; Trackman & Abeles, 1983) ; experiments involving co-administration of putrescine or spermidine (Nathan et al., 1981) with BAC will be used to investigate this hypothesis.
Further work is necessary to establish the precise mechanism for this synergistic effect between two inhibitors with very different sites of action. Previously reported synergistic combinations with DFMO have mostly involved inhibitors which interfere with nucleic acid metabolism, and thus are closely related to polyamine metabolism (Bacchi et al., 1982; Clarkson et al., 1983 , United States Patent Office, 1983 ).
The DFMO used in this study was a generous gift from the MerrellDow Research Institute. Strasbourg, France. R.A.K. acknowledges Table I The enzyme lecithin (phosphatidylcholine): cholesterol acyltransferase (LCAT) cataylses the transfer of a fatty acyl residue from the C-2 position of phosphatidylcholine to the 3-hydroxy group of unesterified cholesterol and is responsible for the formation of nearly all cholesteryl esters of human plasma. Nascent high-density lipoprotein (HDL) and HDL,, a major subspecies of HDL, are believed to be the macromolecular substrates for the reaction which results in the production of the larger, cholesteryl ester-enriched Abbreviations used: LCAT, lecithin (phosphatidylcholine) : cholesterol acyltransferase (EC 2.3. I .43); HDL, high-density lipoprotein; VLDL, very-low-density lipoprotein. lipoprotein particle, HDL,. In view of the negative correlation between the plasma concentration of H D L and the incidence of coronary heart disease (Miller & Miller, 1975) , the present study was aimed at investigating the mechanism underlying the reported increase in the concentration of HDL during prolonged exercise (Wood & Haskell, 1979; Skinner et al., 1985) .
Blood samples were taken, after an overnight fast, from six healthy male volunteer subjects (age 23-37 years) on the day before and the day after a programme consisting of a 23 mile walk on each of four successive days. In a second experiment, blood samples were taken from 10 similar subjects within 1 h before the start of, and again within 5 min of completing, a 42.2 km marathon race (The City of Aberdeen Milk Marathon held in May 1986). Post-exercise LCAT activities were corrected (Dill & Costill, 1974) for changes in plasma volume in the case of the marathon.
Plasma LCAT activity was measured by the method of Stokke & Norum (1971) . Lipoproteins were isolated from
